Percutaneous transluminal coronary angioplasty catheter MagicTouch SCB

coronaryballoondrug eluting

Presentation
MagicTouch is a sirolimus-based drug-coated balloon catheter (MagicTouch – SCB) designed for use in coronary arteries and specifically indicated for the treatment of in‑stent restenosis. The device features a low profile and excellent trackability and incorporates Nanolute technology with a circumferential coating to promote homogeneous drug distribution across lesions.

Clinical-therapeutic indications

• Treatment of in‑stent restenosis.
• De novo lesions in patients at high risk of restenosis.
• Bifurcation lesions (supports single‑stent strategy and reduces side‑branch complications).
• Small‑calibre vessels and challenging anatomies while preserving luminal diameter.

Technology and mechanism of action
MagicTouch SCB is manufactured using Nanolute technology that applies a circumferential coating. Under low‑pressure inflation the design achieves 100% coated surface area, enabling homogeneous sirolimus transfer to the vessel wall and controlled drug release during inflation.

Design features

• Active substance: Sirolimus (drug‑coated balloon).
• Circumferential Nanolute coating for uniform coverage.
• Coating applied via low‑pressure inflation resulting in 100% coated area.
• Homogeneous drug release during the inflation period.
• Low profile and high navigability for tortuous anatomies.
• Balloon folding: 3 folds (balloon packing design).

Studies and evidence
Available data include a pharmacokinetic study and a distribution study using labeled sirolimus (DTF) to evaluate drug delivery after treatment with the drug‑coated balloon.

Table - Diameters / Lengths (references)
Balloon diameter (mm) | Balloon length (mm) and reference codes
2.00 : 15 -> 130140, 20 -> 130579, 25 -> –, 30 -> 130141, 40 -> 130142
2.50 : 15 -> 130143, 20 -> 130580, 25 -> 130144, 30 -> 130145, 40 -> 130146
2.75 : 15 -> 130147, 20 -> 130148, 25 -> –, 30 -> 130149, 40 -> 130150
3.00 : 15 -> 130151, 20 -> 130152, 25 -> –, 30 -> –, 40 -> 130154
3.50 : 15 -> 130762, 20 -> 130766, 25 -> –, 30 -> 130763, 40 -> –
4.00 : 15 -> 130764, 20 -> 130767, 25 -> –, 30 -> 130768, 40 -> 130765

Regulatory notice
Restricted use: commercialization may be limited and depends on regulatory registration in the relevant jurisdictions; sale by prescription where required by law.

Characteristics / technical specifications

• Product type: Sirolimus‑based drug‑coated balloon catheter.
• Coating technology: Nanolute circumferential coating.
• Coating coverage: 100% of balloon surface under low‑pressure inflation.
• Balloon folds: 3 folds.
• Drug delivery: Homogeneous distribution during inflation.
• Primary indications: In‑stent restenosis, de novo lesions, bifurcations, small vessels.
• References by diameter/length combinations as per table above.
• Available studies: Pharmacokinetic and labeled‑sirolimus distribution studies.
• Note: Use limited to countries where registered; prescription sale where applicable.